Antony Mattessich's recent sale below the current price of U...
Antony Mattessich's recent sale below the current price of US$5.18 suggests he considered the lower price fair, questioning the recent higher valuation. Insider selling over the last year and sales history suggest caution before buying Ocular Therapeutix shares.
Have Ocular Therapeutix Insiders Been Selling Stock?
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
3169Followers
0Following
7922Visitors
Follow